(19)
(11) EP 3 399 997 A1

(12)

(43) Date of publication:
14.11.2018 Bulletin 2018/46

(21) Application number: 17736215.9

(22) Date of filing: 04.01.2017
(51) International Patent Classification (IPC): 
A61K 38/18(2006.01)
A61K 38/20(2006.01)
 A61K 38/19(2006.01)
G01N 33/50(2006.01)
(86) International application number:
PCT/US2017/012094
(87) International publication number:
WO 2017/120166 (13.07.2017 Gazette 2017/28)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 04.01.2016 US 201662274578 P
04.01.2016 US 201662274551 P

(71) Applicant: Evogen, Inc.
Overland Park, KS 66210 (US)

(72) Inventors:
  • WALLACH, Todd
    Overland Park KS 66210 (US)
  • CRINO, Peter
    Overland Park KS 66210 (US)
  • POLLARD, John
    Overland Park KS 66210 (US)
  • BRAND, Elizabeth
    Overland Park KS 66210 (US)
  • STRAUMAN, Maura
    Overland Park KS 66210 (US)
  • HOLLENBEAK, Christopher
    Overland Park KS 66210 (US)
  • ST.CLAIR, Rich
    Overland Park KS 66210 (US)
  • BOTBYL, Jeffrey
    Overland Park KS 66210 (US)
  • GLEDHILL, John
    Overland Park KS 66210 (US)

(74) Representative: Boult Wade Tennant LLP 
Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT
London WC1X 8BT (GB)

   


(54) BIOMARKERS AND METHODS FOR DETECTION OF SEIZURES AND EPILEPSY